Yu Chen Barrett

Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement

Jean W. Lee, Viswanath Devanarayan, Yu Chen Barrett et al. · Pharmaceutical Research · 2006 · 759 citations

Pharmacy, Biostatistics, Method Validation +11

Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products

Anthony R. Mire‐Sluis, Yu Chen Barrett, Viswanath Devanarayan et al. · Journal of Immunological Methods · 2004 · 621 citations

Life Sciences, Biotechnology, Immunology +13

Apixaban, an oral, direct factor <scp>X</scp>a inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects

Charles Frost, Jessie J. Wang, Sunil Nepal et al. · British Journal of Clinical Pharmacology · 2012 · 363 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay

Zhaoqing Wang, Charles Frost, Andrew Shenker et al. · Thrombosis and Haemostasis · 2010 · 353 citations

Medicine, Pharmacology, Pharmacotherapy +17

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor<scp>X</scp>a inhibitor, in healthy subjects

Charles Frost, Sunil Nepal, Jessie Wang et al. · British Journal of Clinical Pharmacology · 2013 · 282 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17